Vertex Appoints Katharine Jensen as Head of Corporate Social Responsibility
September 10 2018 - 9:11AM
Business Wire
-- Ms. Jensen to oversee global CSR efforts and
lead The Vertex Foundation --
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that Katharine Jensen has been appointed Head of
Corporate Social Responsibility (CSR). In this role, Ms. Jensen
will oversee all aspects of Vertex’s global CSR efforts, leading
our 10-year, $500 million corporate giving commitment, which is
focused on providing patient and caregiver support, including
access to our medicines; expanding Vertex’s commitment to science,
technology, engineering, art and math (STEAM) education; developing
young physicians and scientists; and investing in our communities.
Ms. Jensen will also serve as the Executive Director of The Vertex
Foundation, a 501(c)(3) organization and long-term source of
charitable giving.
“We are delighted to welcome Katharine to the Vertex family as
we begin the next chapter in our efforts to give back to patients
and the community,” said Jeffrey Leiden, M.D., Ph.D., Chairman,
President and Chief Executive Officer of Vertex. “Her depth of
experience in creating, launching and managing successful CSR
programs, combined with her strong business acumen and passion for
changing lives, makes her a tremendous addition to our team as we
look to expand our corporate giving initiatives.”
“Vertex is deeply committed to patients, communities and
stakeholders as evidenced by its 10-year corporate giving
commitment and creation of The Vertex Foundation,” said Ms. Jensen.
“Together with partners and colleagues, I look forward to advancing
Vertex’s CSR strategy and programs to achieve even greater
impact.”
Ms. Jensen is an accomplished executive with 15 years of
international CSR experience. Prior to joining Vertex, Ms. Jensen
spent 10 years leading global CSR efforts for AbbVie and Abbott
Laboratories. She was responsible for CSR strategy, reporting and
stakeholder engagement, and created award-winning volunteering,
philanthropy and sustainability initiatives. Under her leadership,
AbbVie was industry leader in the 2016 and 2017 Dow Jones
Sustainability Index. Previously, Ms. Jensen worked at APCO
Worldwide where she advised Fortune 100 clients on CSR programs and
reporting. Ms. Jensen received her BA from Boston College and her
MBA from University College Dublin Michael Smurfit Graduate
Business School.
About VertexVertex is a global biotechnology company that
invests in scientific innovation to create transformative medicines
for people with serious and life-threatening diseases. In addition
to clinical development programs in CF, Vertex has more than a
dozen ongoing research programs focused on the underlying
mechanisms of other serious diseases. Founded in 1989 in Cambridge,
Mass., Vertex's headquarters is now located in Boston's Innovation
District. Today, the company has research and development sites and
commercial offices in the United States, Europe, Canada and
Australia. Vertex is consistently recognized as one of the
industry's top places to work, including being named to Science
magazine's Top Employers in the life sciences ranking for eight
years in a row.
For additional information and the latest updates from the
company, please visit www.vrtx.com.
(VRTX-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180910005534/en/
Vertex Pharmaceuticals IncorporatedInvestors:Michael
Partridge, +1 617-341-6108orEric Rojas, +1 617-961-7205orZach
Barber, +1 617-341-6470orMedia:Heather Nichols,
617-341-6992mediainfo@vrtx.com
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024